We are pleased to invite you to the Peripheral T-cell Lymphomas-Challenges in Diagnosis and Treatment,
a satellite symposium to precede the 51st American Society of Hematology Annual Meeting.
In general, the prognosis for most subtypes of peripheral T-cell lymphoma (PTCL) has been poor, and
therapies have proven ineffective. Practitioners who wish to provide the best possible care for their
patients must be aware of the diverse strategies for managing PTCL. Such information will be presented by
national and international experts in the field, who will propose potential solutions for diagnosing and
treating these malignancies. Among the topics to be addressed at the symposium are enhancing existing approaches
to PTCL, the status of ongoing collaborative efforts, and novel agents in development for PTCL.
Accreditation Statement
Hemedicus, Inc is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
Hemedicus designates this activity for a maximum of 3 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
(Back to Meetings)
